• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新利用二甲双胍治疗胃肠道癌症。

Repurposing metformin for the treatment of gastrointestinal cancer.

作者信息

Cunha Júnior Ademar Dantas, Bragagnoli Arinilda Campos, Costa Felipe Osório, Carvalheira José Barreto Campello

机构信息

Department of Internal Medicine, Division of Oncology, University of Campinas (UNICAMP), Campinas 13083-970, São Paulo, Brazil.

Division of Oncology, Hospital de Câncer de Barretos, Barretos 14784-400, São Paulo, Brazil.

出版信息

World J Gastroenterol. 2021 May 7;27(17):1883-1904. doi: 10.3748/wjg.v27.i17.1883.

DOI:10.3748/wjg.v27.i17.1883
PMID:34007128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8108031/
Abstract

Diabetes mellitus type 2 and cancer share many risk factors. The pleiotropic insulin-dependent and insulin-independent effects of metformin might inhibit pathways that are frequently amplified in neoplastic tissue. Particularly, modulation of inflammation, metabolism, and cell cycle arrest are potential therapeutic cancer targets utilized by metformin to boost the anti-cancer effects of chemotherapy. Studies and models have demonstrated the potential of metformin as a chemo- and radiosensitizer, besides its chemopreventive and direct therapeutic activity in digestive system (DS) tumors. Hence, these aspects have been considered in many cancer clinical trials. Case-control and cohort studies and associated meta-analyses have evaluated DS cancer risk and metformin usage, especially in colorectal cancer, pancreatic cancer, and hepatocellular carcinoma. Most clinical studies have demonstrated the protective role of metformin in the risk for DS cancers and survival rates. On the other hand, the ability of metformin to enhance the actions of chemotherapy for gastric and biliary cancers is yet to be investigated. This article reviews the current findings on the anti-cancer mechanisms of metformin and its apparatus from pre-clinical and ongoing studies in DS malignancies.

摘要

2型糖尿病和癌症有许多共同的风险因素。二甲双胍的多效胰岛素依赖性和非胰岛素依赖性作用可能会抑制肿瘤组织中经常被放大的信号通路。特别是,炎症调节、代谢调节和细胞周期阻滞是二甲双胍用于增强化疗抗癌效果的潜在治疗性癌症靶点。研究和模型已经证明,除了在消化系统(DS)肿瘤中的化学预防和直接治疗活性外,二甲双胍还具有作为化疗增敏剂和放疗增敏剂的潜力。因此,许多癌症临床试验都考虑了这些方面。病例对照研究、队列研究及相关的荟萃分析评估了DS癌症风险和二甲双胍的使用情况,尤其是在结直肠癌、胰腺癌和肝细胞癌方面。大多数临床研究都证明了二甲双胍在DS癌症风险和生存率方面的保护作用。另一方面,二甲双胍增强胃癌和胆管癌化疗效果的能力尚待研究。本文综述了二甲双胍抗癌机制的当前研究结果及其在DS恶性肿瘤临床前和正在进行的研究中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/8108031/d2abba4b891e/WJG-27-1883-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/8108031/d2abba4b891e/WJG-27-1883-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec9/8108031/d2abba4b891e/WJG-27-1883-g001.jpg

相似文献

1
Repurposing metformin for the treatment of gastrointestinal cancer.重新利用二甲双胍治疗胃肠道癌症。
World J Gastroenterol. 2021 May 7;27(17):1883-1904. doi: 10.3748/wjg.v27.i17.1883.
2
Metformin and blood cancers.二甲双胍与血液癌症。
Clinics (Sao Paulo). 2018 Sep 6;73(suppl 1):e412s. doi: 10.6061/clinics/2018/e412s.
3
[Metformin, an antidiabetic molecule with anti-cancer properties].二甲双胍,一种具有抗癌特性的抗糖尿病分子
Rev Med Liege. 2013 Sep;68(9):444-9.
4
How far along are we in revealing the connection between metformin and colorectal cancer?在揭示二甲双胍与结直肠癌之间的联系方面,我们进展到什么程度了?
World J Gastroenterol. 2021 Apr 14;27(14):1362-1368. doi: 10.3748/wjg.v27.i14.1362.
5
[Which anti-tumour benefits to be expected from metformin?].二甲双胍有望带来哪些抗肿瘤益处?
Ann Endocrinol (Paris). 2013 May;74(2):137-47. doi: 10.1016/j.ando.2013.02.009. Epub 2013 Apr 6.
6
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.瑞格列奈:对其在2型糖尿病治疗中应用的药物经济学综述
Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005.
7
Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.胰岛素增强,二甲双胍降低 2 型糖尿病患者结直肠癌风险。
QJM. 2020 Mar 1;113(3):194-200. doi: 10.1093/qjmed/hcz253.
8
[Molecular action of insulin-sensitizing agents].[胰岛素增敏剂的分子作用]
Endokrynol Pol. 2005 May-Jun;56(3):308-13.
9
Metformin and cancer: new applications for an old drug.二甲双胍与癌症:老药新用。
Med Oncol. 2012 Jun;29(2):1314-27. doi: 10.1007/s12032-011-9846-7. Epub 2011 Feb 8.
10
Metformin in cancer.二甲双胍与癌症。
Diabetes Res Clin Pract. 2018 Sep;143:409-419. doi: 10.1016/j.diabres.2018.05.023. Epub 2018 May 26.

引用本文的文献

1
Metformin combined with CB-839 specifically inhibits KRAS-mutant ovarian cancer.二甲双胍联合CB-839可特异性抑制KRAS突变型卵巢癌。
Sci Rep. 2025 Feb 19;15(1):6072. doi: 10.1038/s41598-025-90963-8.
2
Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus.2型糖尿病墨西哥裔美国人肝细胞癌的风险与预后
J Hepatocell Carcinoma. 2025 Jan 21;12:93-106. doi: 10.2147/JHC.S477141. eCollection 2025.
3
Exploring potential biomarkers and lead molecules in gastric cancer by network biology, drug repurposing and virtual screening strategies.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial.二甲双胍联合伊立替康治疗难治性结直肠癌的Ⅱ期临床试验
Br J Cancer. 2021 Mar;124(6):1072-1078. doi: 10.1038/s41416-020-01208-6. Epub 2021 Jan 4.
3
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence.
通过网络生物学、药物再利用和虚拟筛选策略探索胃癌中的潜在生物标志物和先导分子。
Mol Divers. 2025 Jun;29(3):2341-2366. doi: 10.1007/s11030-024-10995-6. Epub 2024 Sep 30.
4
Low BMI patients with advanced mutation-positive NSCLC can get a better outcome from metformin plus EGFR-TKI as first-line therapy: A secondary analysis of a phase 2 randomized clinical trial.低体重指数的晚期突变阳性非小细胞肺癌患者,接受二甲双胍联合表皮生长因子受体酪氨酸激酶抑制剂作为一线治疗可获得更好的疗效:一项2期随机临床试验的二次分析
Chin Med J Pulm Crit Care Med. 2023 Jun 17;1(2):119-124. doi: 10.1016/j.pccm.2023.04.006. eCollection 2023 Jun.
5
Prognostic impact of metformin in solid cancer patients receiving immune checkpoint inhibitors: novel evidences from a multicenter retrospective study.二甲双胍对接受免疫检查点抑制剂治疗的实体癌患者的预后影响:一项多中心回顾性研究的新证据。
Front Pharmacol. 2024 Jul 29;15:1419498. doi: 10.3389/fphar.2024.1419498. eCollection 2024.
6
Metformin in combination with chemotherapy increases apoptosis in gastric cancer cells and counteracts senescence induced by chemotherapy.二甲双胍联合化疗可增加胃癌细胞的凋亡,并对抗化疗诱导的衰老。
Oncol Lett. 2024 Jul 25;28(4):457. doi: 10.3892/ol.2024.14590. eCollection 2024 Oct.
7
Will AMPK be a potential therapeutic target for hepatocellular carcinoma?AMPK会成为肝细胞癌的潜在治疗靶点吗?
Am J Cancer Res. 2024 Jul 15;14(7):3241-3258. doi: 10.62347/YAVK1315. eCollection 2024.
8
Metformin induces tumor immunogenic cell death in ovarian cancer by activating AMPK pathway.二甲双胍通过激活AMPK信号通路诱导卵巢癌发生免疫原性细胞死亡。
Transl Oncol. 2024 Sep;47:102052. doi: 10.1016/j.tranon.2024.102052. Epub 2024 Jul 8.
9
Metformin: From Diabetes to Cancer-Unveiling Molecular Mechanisms and Therapeutic Strategies.二甲双胍:从糖尿病到癌症——揭示分子机制与治疗策略
Biology (Basel). 2024 Apr 27;13(5):302. doi: 10.3390/biology13050302.
10
Research Progress on the Use of Metformin in Leukemia Treatment.二甲双胍在白血病治疗中的应用研究进展。
Curr Treat Options Oncol. 2024 Feb;25(2):220-236. doi: 10.1007/s11864-024-01179-3. Epub 2024 Jan 30.
二甲双胍在胰腺神经内分泌肿瘤患者治疗中的潜在作用:临床前至临床证据综述
Therap Adv Gastroenterol. 2020 Jul 31;13:1756284820927271. doi: 10.1177/1756284820927271. eCollection 2020.
4
Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment.二甲双胍与依维莫司:神经内分泌肿瘤治疗的一种有前景的联合用药方案
Cancers (Basel). 2020 Aug 2;12(8):2143. doi: 10.3390/cancers12082143.
5
Epidemiology of Hepatocellular Carcinoma.肝细胞癌的流行病学
Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):4-13. doi: 10.1002/hep.31288. Epub 2020 Nov 24.
6
The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.二甲双胍对 2 型糖尿病患者胃癌的影响:系统评价和荟萃分析。
Clin Transl Oncol. 2020 Sep;22(9):1580-1590. doi: 10.1007/s12094-020-02304-y. Epub 2020 Feb 14.
7
A Cohort Study of Antihyperglycemic Medication Exposure and Gastric Cancer Risk.一项关于抗高血糖药物暴露与胃癌风险的队列研究。
J Clin Med. 2020 Feb 5;9(2):435. doi: 10.3390/jcm9020435.
8
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
9
Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.二甲双胍预防糖尿病患者肝细胞癌:系统评价。
Ann Hepatol. 2020 May-Jun;19(3):232-237. doi: 10.1016/j.aohep.2019.10.005. Epub 2019 Nov 28.
10
Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest.抗糖尿病药物二甲双胍通过 G0/G1 细胞周期阻滞抑制胆囊癌的细胞增殖和肿瘤生长。
Anticancer Drugs. 2020 Mar;31(3):231-240. doi: 10.1097/CAD.0000000000000870.